CFR 21(PTS1-99):2021

1
1.1 to 1.980
GENERAL ENFORCEMENT REGULATIONS
2
2.5 to 2.125
GENERAL ADMINISTRATIVE RULINGS AND DECISIONS
3
3.1 to 3.10
PRODUCT JURISDICTION
4
4.1 to 4.105
REGULATION OF COMBINATION PRODUCTS
5
5.1100 to 5.1110
ORGANIZATION
6
XXX
7
7.1 to 7.87
ENFORCEMENT POLICY
10
10.1 to 10.206
ADMINISTRATIVE PRACTICES AND PROCEDURES
11
11.1 to 11.300
ELECTRONIC RECORDS; ELECTRONIC SIGNATURES
12
12.1 to 12.159
FORMAL EVIDENTIARY PUBLIC HEARING
13
13.1 to 13.50
PUBLIC HEARING BEFORE A PUBLIC BOARD OF INQUIRY
14
14.1 to 14.174
PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE
15
15.1 to 15.45
PUBLIC HEARING BEFORE THE COMMISSIONER
16
16.1 to 16.120
REGULATORY HEARING BEFORE THE FOOD AND DRUG ADMINISTRATION
17
17.1 to 17.54
CIVIL MONEY PENALTIES HEARINGS
19
19.1 to 19.55
STANDARDS OF CONDUCT AND CONFLICTS OF INTEREST
20
20.1 to 20.120
PUBLIC INFORMATION
21
21.1 to 21.75
PROTECTION OF PRIVACY
25
25.1 to 25.60
ENVIRONMENTAL IMPACT CONSIDERATIONS
26
26.0 to 26.81
MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM AUDIT REPORTS, AND CERTAIN MEDICAL DEVICE PRODUCT EVALUATION REPORTS: UNITED STATES AND THE EUROPEAN COMMUNITY
50
50.1 to 50.56
PROTECTION OF HUMAN SUBJECTS
54
54.1 to 54.6
FINANCIAL DISCLOSURE BY CLINICAL INVESTIGATORS
56
56.101 to 56.124
INSTITUTIONAL REVIEW BOARDS
58
58.1 to 58.219
GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES
60
60.1 to 60.46
PATENT TERM RESTORATION
70
70.3 to 70.55
COLOR ADDITIVES
71
71.1 to 71.37
COLOR ADDITIVE PETITIONS
73
73.1 to 73.3129
LISTING OF COLOR ADDITIVES EXEMPT FROM CERTIFICATION
74
74.101 to 74.3710
LISTING OF COLOR ADDITIVES SUBJECT TO CERTIFICATION
80
80.10 to 80.39
COLOR ADDITIVE CERTIFICATION
81
81.1 to 81.30
GENERAL SPECIFICATIONS AND GENERAL RESTRICTIONS FOR PROVISIONAL COLOR ADDITIVES FOR USE IN FOODS, DRUGS, AND COSMETICS
82
82.3 to 82.2707a
LISTING OF CERTIFIED PROVISIONALLY LISTED COLORS AND SPECIFICATIONS
83-98
[RESERVED]
99
99.1 to 99.501
DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES